chr5-151505656-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_001447.3(FAT2):c.12959C>T(p.Ala4320Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001447.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAT2 | NM_001447.3 | c.12959C>T | p.Ala4320Val | missense_variant | 24/24 | ENST00000261800.6 | NP_001438.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAT2 | ENST00000261800.6 | c.12959C>T | p.Ala4320Val | missense_variant | 24/24 | 1 | NM_001447.3 | ENSP00000261800.5 | ||
FAT2 | ENST00000520200.5 | c.3275C>T | p.Ala1092Val | missense_variant | 11/11 | 1 | ENSP00000429678.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000640 AC: 16AN: 250172Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135706
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461786Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727200
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2021 | The c.12959C>T (p.A4320V) alteration is located in exon 23 (coding exon 23) of the FAT2 gene. This alteration results from a C to T substitution at nucleotide position 12959, causing the alanine (A) at amino acid position 4320 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at